[HTML][HTML] Suppl 1: microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation

C Kourtesi, AR Ball, YY Huang, SM Jachak… - The open …, 2013 - ncbi.nlm.nih.gov
Conventional antimicrobials are increasingly ineffective due to the emergence of multidrug-
resistance among pathogenic microorganisms. The need to overcome these deficiencies …

Microbial efflux pump inhibition: tactics and strategies

GP Tegos, M Haynes, J Jacob Strouse… - Current …, 2011 - ingentaconnect.com
Traditional antimicrobials are increasingly suffering from the emergence of multidrug
resistance among pathogenic microorganisms. To overcome these deficiencies, a range of …

[HTML][HTML] Role of bacterial efflux pumps in antibiotic resistance, virulence, and strategies to discover novel efflux pump inhibitors

A Gaurav, P Bakht, M Saini, S Pandey… - …, 2023 - microbiologyresearch.org
The problem of antibiotic resistance among pathogenic bacteria has reached a crisis level.
The treatment options against infections caused by multiple drug-resistant bacteria are …

Understanding efflux in Gram-negative bacteria: opportunities for drug discovery

HP Schweizer - Expert opinion on drug discovery, 2012 - Taylor & Francis
Introduction: Bacteria evolved an arsenal of mechanisms to deal with toxic compounds and
metabolic stresses, including antimicrobial agents. Efflux pumps are major players in the …

Practical applications and feasibility of efflux pump inhibitors in the clinic—a vision for applied use

O Lomovskaya, KA Bostian - Biochemical pharmacology, 2006 - Elsevier
The world of antibiotic drug discovery and development is driven by the necessity to
overcome antibiotic resistance in common Gram-positive and Gram-negative pathogens …

Current advances in developing inhibitors of bacterial multidrug efflux pumps

HY Mahmood, S Jamshidi… - Current medicinal …, 2016 - ingentaconnect.com
Antimicrobial resistance represents a significant challenge to future healthcare provision. An
acronym ESKAPEE has been derived from the names of the organisms recognised as the …

[HTML][HTML] Efflux pump inhibitors for bacterial pathogens: From bench to bedside

A Sharma, VK Gupta, R Pathania - Indian Journal of Medical …, 2019 - journals.lww.com
With the advent of antibiotics, bacterial infections were supposed to be a thing of past.
However, this instead led to the selection and evolution of bacteria with mechanisms to …

[图书][B] Efflux-mediated antimicrobial resistance in bacteria: mechanisms, regulation and clinical implications

XZ Li, CA Elkins, HI Zgurskaya - 2016 - Springer
Antibiotics are vital to modern medicine. However, bacterial resistance constitutes a growing
threat to effective antimicrobial therapy worldwide. Indeed, antimicrobial resistance …

[HTML][HTML] Update on the discovery of efflux pump inhibitors against critical priority Gram-negative bacteria

N Compagne, A Vieira Da Cruz, RT Müller… - Antibiotics, 2023 - mdpi.com
Antimicrobial resistance (AMR) has become a major problem in public health leading to an
estimated 4.95 million deaths in 2019. The selective pressure caused by the massive and …

Inhibition of bacterial efflux pumps: a new strategy to combat increasing antimicrobial agent resistance

GW Kaatz - Expert Opinion on Emerging Drugs, 2002 - Taylor & Francis
Resistance to multiple drugs in medically important bacteria results in therapeutic
challenges for the clinician. The mechanisms by which bacteria evade the effects of …